|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for credit losses | |||||
| Stock-based compensation | |||||
| Deferred income taxes | |||||
| Excess tax benefit on stock-based compensation | |||||
| Loss on disposal groups held for sale | |||||
| Other operating activities | |||||
| Changes in operating elements: | |||||
| Receivables | |||||
| Contract assets | |||||
| Prepaid expenses and other | |||||
| Right of use asset | |||||
| Accounts payable and outstanding checks | |||||
| Accrued compensation | |||||
| Accrued transportation expense | |||||
| Accrued income taxes | |||||
| Other accrued liabilities | |||||
| Lease liability | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Purchases of property and equipment | |||||
| Purchases and development of software | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from divestiture | |||||
| Proceeds from sale of property and equipment | |||||
| Net cash used for investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from stock issued for employee benefit plans | |||||
| Stock tendered for payment of withholding taxes | |||||
| Repurchase of common stock | |||||
| Cash dividends | |||||
| Proceeds from long-term borrowings | |||||
| Payments on long-term borrowings | |||||
| Proceeds from short-term borrowings | |||||
| Payments on short-term borrowings | |||||
| Net cash used for financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net change in cash and cash equivalents, including cash and cash equivalents classified within assets held for sale | |||||
| Less: net increase in cash and cash equivalents within assets held for sale | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental cash flow disclosures | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Accrued share repurchases held in other accrued liabilities |
Loading...